Certified by Founder Lodge
4BIO Capital
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $132,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.
4BIO’s objective is to invest in, support, and grow early stage companies developing
| Company | Date | Round | Raised |
|---|---|---|---|
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
 Actithera |
July, 09 ,2025 | Series A | $75,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
